MDT

88.44

-1.53%↓

VEEV

227.74

-1.64%↓

A

113.65

-2.76%↓

HQY

87.08

-1.46%↓

PDCO

31.26

0%↓

MDT

88.44

-1.53%↓

VEEV

227.74

-1.64%↓

A

113.65

-2.76%↓

HQY

87.08

-1.46%↓

PDCO

31.26

0%↓

MDT

88.44

-1.53%↓

VEEV

227.74

-1.64%↓

A

113.65

-2.76%↓

HQY

87.08

-1.46%↓

PDCO

31.26

0%↓

MDT

88.44

-1.53%↓

VEEV

227.74

-1.64%↓

A

113.65

-2.76%↓

HQY

87.08

-1.46%↓

PDCO

31.26

0%↓

MDT

88.44

-1.53%↓

VEEV

227.74

-1.64%↓

A

113.65

-2.76%↓

HQY

87.08

-1.46%↓

PDCO

31.26

0%↓

Search

Zoetis Inc

Suletud

SektorTervishoid

161.75 -1.67

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

161.14

Max

165.54

Põhinäitajad

By Trading Economics

Sissetulek

-101M

581M

Müük

-83M

2.3B

P/E

Sektori keskmine

30.101

63.778

Aktsiakasum

1.4

Dividenditootlus

1.21

Kasumimarginaal

25.076

Töötajad

13,800

EBITDA

-133M

906M

Soovitused

By TipRanks

Soovitused

Tugev "osta" hinnang

12 kuu keskmine prognoos

+28.29% upside

Dividendid

By Dow Jones

Dividenditootlus

Sektori keskmine

1.21%

2.39%

Järgmine tulemuste avaldamine

6. mai 2025

Järgmine aktsia dividendi kuupäev (ex-date)

21. apr 2025

Turustatistika

By TradingEconomics

Turukapital

-5.1B

74B

Eelmine avamishind

163.42

Eelmine sulgemishind

161.75

Uudiste sentiment

By Acuity

37%

63%

123 / 386 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Strong Bearish Evidence

Zoetis Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

4. nov 2024, 12:47 UTC

Tulu

Zoetis Lifts Guidance On Strong Demand as 3Q Beats Market Views

6. aug 2024, 11:52 UTC

Tulu

Zoetis Raises Guidance After 2Q Sales, Earnings Rise

20. veebr 2025, 08:00 UTC

Peamised uudised

A Bird-Flu Vaccine Could Bring Down Egg Prices. Why the Poultry Industry Is Fighting It. -- Barrons.com

13. veebr 2025, 13:47 UTC

Tulu

Zoetis Plunges 9% As 2025 Guidance Misses Expectations -- IBD

13. veebr 2025, 12:09 UTC

Tulu

Zoetis Sees FY25 Adj EPS $6-Adj EPS $6.10 >ZTS

13. veebr 2025, 12:08 UTC

Tulu

Zoetis Sees FY25 Rev $9.225B-$9.375B >ZTS

13. veebr 2025, 12:08 UTC

Tulu

Zoetis Sees FY25 EPS $5.70-EPS $5.80 >ZTS

13. veebr 2025, 12:00 UTC

Tulu

Zoetis 4Q EPS $1.29 >ZTS

13. veebr 2025, 12:00 UTC

Tulu

Zoetis 4Q Rev $2.32B >ZTS

13. veebr 2025, 12:00 UTC

Tulu

Zoetis 4Q Net $581M >ZTS

4. nov 2024, 14:05 UTC

Tulu

Zoetis Barks Up A Third-Quarter Beat And Raise, But Stock Slips -- IBD

4. nov 2024, 12:06 UTC

Tulu

Zoetis Sees 2024 Rev $9.2B-$9.3B >ZTS

4. nov 2024, 12:06 UTC

Tulu

Zoetis Sees 2024 Adj EPS $5.86-Adj EPS $5.92 >ZTS

4. nov 2024, 12:05 UTC

Tulu

Zoetis 3Q Adj EPS $1.58 >ZTS

4. nov 2024, 12:00 UTC

Tulu

Zoetis 3Q Net $682M >ZTS

4. nov 2024, 12:00 UTC

Tulu

Zoetis 3Q EPS $1.50 >ZTS

4. nov 2024, 12:00 UTC

Tulu

Zoetis 3Q Rev $2.39B >ZTS

6. aug 2024, 11:44 UTC

Tulu

Zoetis Earnings Growth Picks Up, Tops Views -- IBD

6. aug 2024, 11:09 UTC

Tulu

Zoetis Raises 2024 Operational Revenue Growth View to 9%-11% >ZTS

6. aug 2024, 11:08 UTC

Tulu

Zoetis Raises 2024 View To Adj EPS $5.78-Adj EPS $5.88 >ZTS

6. aug 2024, 11:08 UTC

Tulu

Zoetis Raises 2024 View To Rev $9.1B-$9.25B >ZTS

6. aug 2024, 11:08 UTC

Tulu

Zoetis 2Q Adj EPS $1.56 >ZTS

6. aug 2024, 11:00 UTC

Tulu

Zoetis 2Q Net $624M >ZTS

6. aug 2024, 11:00 UTC

Tulu

Zoetis 2Q Rev $2.36B >ZTS

6. aug 2024, 11:00 UTC

Tulu

Zoetis 2Q EPS $1.37 >ZTS

2. mai 2024, 17:43 UTC

Tulu

Zoetis Stock Climbs on Earnings Beat, but Worries Linger Over Key Medicine -- Barrons.com

2. mai 2024, 13:06 UTC

Tulu

Zoetis Stock Climbs on Earnings Beat, but Worries Linger Over Key Medicine -- Barrons.com

2. mai 2024, 11:27 UTC

Tulu

Zoetis Earnings Top; Pet Drugmaker Rises -- IBD

2. mai 2024, 11:00 UTC

Tulu

Zoetis 1Q Net $599M >ZTS

2. mai 2024, 11:00 UTC

Tulu

Zoetis 1Q EPS $1.31 >ZTS

Võrdlus sarnastega

Hinnamuutus

Zoetis Inc Prognoos

Hinnasiht

By TipRanks

28.29% tõus

12 kuu keskmine prognoos

Keskmine 207.71 USD  28.29%

Kõrge 242 USD

Madal 180 USD

Põhineb 8 Wall Streeti analüütiku instrumendi Zoetis Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

8 ratings

7

Osta

1

Hoia

0

Müü

Tehniline skoor

By Trading Central

161.695 / 163.24Toetus ja vastupanu

Lühikene perspektiiv

Strong Bearish Evidence

Keskpikk perspektiiv

Bearish Evidence

Pikk perspektiiv

Strong Bearish Evidence

Sentiment

By Acuity

123 / 386 Pingereas Tervishoid

Uudiste sentiment

Languse märgid

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Üle keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Zoetis Inc

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.